세계의 뇌척수액(CSF) 관리 시장 : 규모, 점유율, 동향 분석, 기회, 예측 보고서(2019-2030년)

Global Cerebrospinal Fluid (CSF) Management Market Size Set to More Than Double Touching USD 3 Billion by 2030

Global Cerebrospinal Fluid (CSF) Management Market is flourishing because of the increasing burden of hydrocephalus and other neurological disorders and growing geriatric population.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Cerebrospinal Fluid (CSF) Management Market size at USD 1.37 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Cerebrospinal Fluid (CSF) Management Market size to expand at a CAGR of 5.12% reaching a value of USD 2.98 billion by 2030. The rising incidence of illnesses linked to CSF, such as meningitis, subarachnoid hemorrhage, and hydrocephalus, is one of the main driving reasons for the Global Cerebrospinal Fluid (CSF) Management Market. Furthermore, it is projected that the Global Cerebrospinal Fluid (CSF) Management Market will be driven by a growing elderly population and the increasing incidence of illnesses like Parkinson's and Alzheimer's during the period in analysis.

Opportunity: Growing investments in healthcare sector by developing countries

Major emerging economies, including India and Brazil, have been significantly investing in their healthcare sector to strengthen the healthcare infrastructure across their countries owing to an increasing patient pool and to boost medical tourism in their respective countries. The high prevalence of hydrocephalus in developing and lower-income countries is mainly attributed to low socioeconomic status and a lack of folic acid supplementation. As a result, the demand for cerebrospinal fluid (CSF) management is projected to grow, driving the overall market.

Impact of Escalating Geopolitical Tensions on Global Cerebrospinal Fluid (CSF) Management Market

The escalating geopolitical tensions negatively impact the growth of the Global Cerebrospinal Fluid (CSF) Management Market. Situations like war, conflicts, and genocide impact the patient's accessibility to proper healthcare services and result in a shortage of medical supplies. Russia and Israel, for instance, destroyed several hospitals in Ukraine and Palestine, respectively, which resulted in the breakdown of the entire healthcare system and the displacement of many healthcare workers. Many other countries that are facing geopolitical tensions have limited resources to acquire medical supplies for performing cerebrospinal fluid (CSF) management, which limits its global market growth.

Global Cerebrospinal Fluid (CSF) Management Market

Segmental Coverage

Global Cerebrospinal Fluid (CSF) Management Market - By End User

Based on the end user, the Global Cerebrospinal Fluid (CSF) Management Market is segmented into pediatric, adult, and geriatric. The pediatric segment accounts for the highest market share owing to the increasing prevalence of congenital hydrocephalus among children. Overabundance of cerebrospinal fluid (CSF) in the brain from birth results in congenital hydrocephalus. As a result, the number of shunt procedures performed on children is also rising at a high rate, driving the global cerebrospinal fluid (CSF) management market.

Global Cerebrospinal Fluid (CSF) Management Market - By Region

The in-depth research report on the Global Cerebrospinal Fluid (CSF) Management Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Cerebrospinal Fluid (CSF) Management Market. The region's dominance in the market is mainly attributed to the growing elderly population and the prevalence of nervous disorders. Furthermore, extensive research and development activities in this field and approvals of new products by the US FDA are anticipated to present lucrative growth opportunities to the major players in the Cerebrospinal Fluid (CSF) Management Market over the forecast period.

Competitive Landscape

Major players operating in the Global Cerebrospinal Fluid (CSF) Management Market include Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences, Natus Medical Incorporated, Sophysa, Aesculap AG, Spiegelberg GmbH & Co. KG, Moeller Medica, IRRAS AB, Argi Group, and Sophysa.

These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Cerebrospinal Fluid (CSF) Management Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Cerebrospinal Fluid (CSF) Management Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Cerebrospinal Fluid (CSF) Management Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing Burden of Hydrocephalus and Other Neurological Disorders
    • 3.2.1.2. Growing Geriatric Population
    • 3.2.1.3. Increasing Healthcare Awareness
    • 3.2.1.4. Growing Adoption of Minimally Invasive Solutions
  • 3.2.2. Restraints
    • 3.2.2.1. High Cost of Procedures and Devices
    • 3.2.2.2. Lack of Awareness of Treatment Options
    • 3.2.2.3. Dearth of Skilled Professionals
  • 3.2.3. Opportunities
    • 3.2.3.1. Advancements in Minimally Invasive Surgical Techniques and Development of New CSF Drainage Devices
    • 3.2.3.2. Focus on Minimally Invasive Procedures
    • 3.2.3.3. Integration of Telemedicine and Remote Monitoring with CSF Management Devices
  • 3.2.4. Challenges
    • 3.2.4.1. Reimbursement Challenges
    • 3.2.4.2. Cybersecurity Threats
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Cerebrospinal Fluid (CSF) Management Market: Marketing Strategies

5. Global Cerebrospinal Fluid (CSF) Management Market, Geographical Analysis, 2023

• 5.1. Global Cerebrospinal Fluid (CSF) Management Market, Geographical Analysis, 2023
• 5.2. Global Cerebrospinal Fluid (CSF) Management Market, Market Attractiveness Analysis, 2024-2030

6. Global Cerebrospinal Fluid (CSF) Management Market Overview

• 6.1. Market Size & Forecast, 2019-2030
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share and Forecast
  • 6.2.1. By Product
    • 6.2.1.1. CSF Shunts
    • 6.2.1.2. External Drainage Systems
  • 6.2.2. By End User
    • 6.2.2.1. Pediatric
    • 6.2.2.2. Adult
    • 6.2.2.3. Geriatric
  • 6.2.3. By Region
    • 6.2.3.1. North America
    • 6.2.3.2. Europe
    • 6.2.3.3. Asia Pacific (APAC)
    • 6.2.3.4. Latin America (LATAM)
    • 6.2.3.5. Middle East and Africa (MEA)

7. North America Cerebrospinal Fluid (CSF) Management Market

• 7.1. Market Size & Forecast, 2019-2030
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
    • 7.2.3.1. United States
    • 7.2.3.1.1. By Product
    • 7.2.3.1.2. By End User
    • 7.2.3.2. Canada
    • 7.2.3.2.1. By Product
    • 7.2.3.2.2. By End User

8. Europe Cerebrospinal Fluid (CSF) Management Market

• 8.1. Market Size & Forecast, 2019-2030
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
    • 8.2.3.1. Germany
    • 8.2.3.1.1. By Product
    • 8.2.3.1.2. By End User
    • 8.2.3.2. United Kingdom
    • 8.2.3.2.1. By Product
    • 8.2.3.2.2. By End User
    • 8.2.3.3. Italy
    • 8.2.3.3.1. By Product
    • 8.2.3.3.2. By End User
    • 8.2.3.4. France
    • 8.2.3.4.1. By Product
    • 8.2.3.4.2. By End User
    • 8.2.3.5. Spain
    • 8.2.3.5.1. By Product
    • 8.2.3.5.2. By End User
    • 8.2.3.6. Belgium
    • 8.2.3.6.1. By Product
    • 8.2.3.6.2. By End User
    • 8.2.3.7. Russia
    • 8.2.3.7.1. By Product
    • 8.2.3.7.2. By End User
    • 8.2.3.8. Rest of Europe
    • 8.2.3.8.1. By Product
    • 8.2.3.8.2. By End User

9. Asia Pacific Cerebrospinal Fluid (CSF) Management Market

• 9.1. Market Size & Forecast, 2019-2030
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
    • 9.2.3.1. China
    • 9.2.3.1.1. By Product
    • 9.2.3.1.2. By End User
    • 9.2.3.2. India
    • 9.2.3.2.1. By Product
    • 9.2.3.2.2. By End User
    • 9.2.3.3. Japan
    • 9.2.3.3.1. By Product
    • 9.2.3.3.2. By End User
    • 9.2.3.4. South Korea
    • 9.2.3.4.1. By Product
    • 9.2.3.4.2. By End User
    • 9.2.3.5. Australia & New Zealand
    • 9.2.3.5.1. By Product
    • 9.2.3.5.2. By End User
    • 9.2.3.6. Indonesia
    • 9.2.3.6.1. By Product
    • 9.2.3.6.2. By End User
    • 9.2.3.7. Malaysia
    • 9.2.3.7.1. By Product
    • 9.2.3.7.2. By End User
    • 9.2.3.8. Singapore
    • 9.2.3.8.1. By Product
    • 9.2.3.8.2. By End User
    • 9.2.3.9. Vietnam
    • 9.2.3.9.1. By Product
    • 9.2.3.9.2. By End User
    • 9.2.3.10. Rest of APAC
    • 9.2.3.10.1. By Product
    • 9.2.3.10.2. By End User

10. Latin America Cerebrospinal Fluid (CSF) Management Market

• 10.1. Market Size & Forecast, 2019-2030
  • 10.1.1. By Value (USD Billion)
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End User
  • 10.2.3. By Country
    • 10.2.3.1. Brazil
    • 10.2.3.1.1. By Product
    • 10.2.3.1.2. By End User
    • 10.2.3.2. Mexico
    • 10.2.3.2.1. By Product
    • 10.2.3.2.2. By End User
    • 10.2.3.3. Argentina
    • 10.2.3.3.1. By Product
    • 10.2.3.3.2. By End User
    • 10.2.3.4. Peru
    • 10.2.3.4.1. By Product
    • 10.2.3.4.2. By End User
    • 10.2.3.5. Rest of LATAM
    • 10.2.3.5.1. By Product
    • 10.2.3.5.2. By End User

11. Middle East & Africa Cerebrospinal Fluid (CSF) Management Market

• 11.1. Market Size & Forecast, 2019-2030
  • 11.1.1. By Value (USD Billion)
• 11.2. Market Share & Forecast
  • 11.2.1. By Product
  • 11.2.2. By End User
  • 11.2.3. By Country
    • 11.2.3.1. Saudi Arabia
    • 11.2.3.1.1. By Product
    • 11.2.3.1.2. By End User
    • 11.2.3.2. UAE
    • 11.2.3.2.1. By Product
    • 11.2.3.2.2. By End User
    • 11.2.3.3. Qatar
    • 11.2.3.3.1. By Product
    • 11.2.3.3.2. By End User
    • 11.2.3.4. Kuwait
    • 11.2.3.4.1. By Product
    • 11.2.3.4.2. By End User
    • 11.2.3.5. South Africa
    • 11.2.3.5.1. By Product
    • 11.2.3.5.2. By End User
    • 11.2.3.6. Nigeria
    • 11.2.3.6.1. By Product
    • 11.2.3.6.2. By End User
    • 11.2.3.7. Algeria
    • 11.2.3.7.1. By Product
    • 11.2.3.7.2. By End User
    • 11.2.3.8. Rest of MEA
    • 11.2.3.8.1. By Product
    • 11.2.3.8.2. By End User

12. Competitive Landscape

• 12.1. List of Key Players and Their Offerings
• 12.2. Global Cerebrospinal Fluid (CSF) Management Market Share Analysis, 2023
• 12.3. Competitive Benchmarking, By Operating Parameters
• 12.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

13. Impact of Escalating Geopolitical Tensions on Global Cerebrospinal Fluid (CSF) Management Market

14. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

• 14.1. Medtronic Plc
• 14.2. B. Braun Melsungen AG
• 14.3. Integra Lifesciences
• 14.4. Natus Medical Incorporated
• 14.5. Sophysa
• 14.6. Aesculap AG
• 14.7. Spiegelberg GmbH & Co. KG
• 14.8. Moeller Medica
• 14.9. IRRAS AB
• 14.10. Argi Grup
• 14.11. Sophysa
• 14.12. Other Prominent Players

15. Key Strategic Recommendations

16. Research Methodology

• 16.1. Qualitative Research
  • 16.1.1. Primary & Secondary Research
• 16.2. Quantitative Research
• 16.3. Market Breakdown & Data Triangulation
  • 16.3.1. Secondary Research
  • 16.3.2. Primary Research
• 16.4. Breakdown of Primary Research Respondents, By Region
• 16.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable